Moser Wealth Advisors LLC Reduces Position in The Clorox Company (NYSE:CLX)

Moser Wealth Advisors LLC lessened its holdings in shares of The Clorox Company (NYSE:CLX) by 3.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,280 shares of the company’s stock after selling 150 shares during the quarter. Moser Wealth Advisors LLC’s holdings in Clorox were worth $697,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also modified their holdings of the business. Russell Investments Group Ltd. lifted its stake in shares of Clorox by 25.7% during the 1st quarter. Russell Investments Group Ltd. now owns 149,357 shares of the company’s stock valued at $22,862,000 after buying an additional 30,497 shares in the last quarter. Entropy Technologies LP purchased a new position in shares of Clorox during the 1st quarter valued at $961,000. State Board of Administration of Florida Retirement System lifted its stake in shares of Clorox by 4.1% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 150,011 shares of the company’s stock valued at $23,738,000 after buying an additional 5,936 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of Clorox by 9.4% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 186,301 shares of the company’s stock valued at $28,525,000 after buying an additional 16,012 shares in the last quarter. Finally, Wilkins Investment Counsel Inc. increased its holdings in Clorox by 51.6% in the 1st quarter. Wilkins Investment Counsel Inc. now owns 16,514 shares of the company’s stock valued at $2,528,000 after acquiring an additional 5,624 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Clorox stock opened at $164.78 on Wednesday. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $169.09. The firm has a market capitalization of $20.40 billion, a P/E ratio of 57.41, a price-to-earnings-growth ratio of 3.05 and a beta of 0.41. The company’s 50-day moving average is $162.28 and its 200 day moving average is $146.95.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same period last year, the company posted $0.49 earnings per share. Research analysts forecast that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.96%. The ex-dividend date was Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Insider Transactions at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.57% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CLX. Evercore ISI reduced their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and lifted their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. DA Davidson lifted their price target on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Finally, Citigroup lifted their price target on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Clorox currently has a consensus rating of “Hold” and an average target price of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.